News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Kirk Christopher J.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/10/2023 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Granted 190,000 options to buy
@ $6.84, valued at
$1.3M
|
|
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2022 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Granted 170,000 options to buy
@ $14.55, valued at
$2.5M
|
|
01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/05/2020 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Bought 38,461 shares
@ $2.6, valued at
$100k
|
|
01/13/2020 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Granted 125,000 options to buy
@ $3.29, valued at
$411.3k
|
|
08/15/2019 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Bought 5,000 shares
@ $4.608, valued at
$23k
|
|
08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/08/2019 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Granted 87,500 options to buy
@ $22.85, valued at
$2M
|
|
06/27/2018 |
4
| Kirk Christopher J. (President and CSO) has filed a Form 4 on Kezar Life Sciences, Inc.
Txns:
| Granted 26,690 options to buy
@ $5.91, valued at
$157.7k
|
|
|
|